Real-time enrollment status for this proc clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:00 PM UTC
| NCT Number | NCT07470853 |
| Recruiting Status | Recruiting |
| Condition | PROC |
| Phase | PHASE1 |
| Target Enrollment | 265 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Whitehawk Therapeutics, Inc. |
| Last Updated on CT.gov | August 18, 2026 (Aug 18, 2026) |
As of October 12, 2026: Clinical trial NCT07470853 is currently recruiting participants. This phase1 study for proc is actively seeking new participants at 12 locations across the United States. The study is sponsored by Whitehawk Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07470853 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07470853 was last updated Aug 18, 2026 (August 18, 2026). HelloStudys verifies this status automatically.